BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26257960)

  • 1. Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs.
    Lilja AM; Malmsten L; Röjdner J; Voytenko L; Verkhratsky A; Ögren SO; Nordberg A; Marutle A
    Neural Plast; 2015; 2015():370432. PubMed ID: 26257960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels.
    Lilja AM; Röjdner J; Mustafiz T; Thomé CM; Storelli E; Gonzalez D; Unger-Lithner C; Greig NH; Nordberg A; Marutle A
    PLoS One; 2013; 8(3):e58752. PubMed ID: 23554921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
    Feuerbach D; Lingenhoehl K; Olpe HR; Vassout A; Gentsch C; Chaperon F; Nozulak J; Enz A; Bilbe G; McAllister K; Hoyer D
    Neuropharmacology; 2009 Jan; 56(1):254-63. PubMed ID: 18793655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin prevents β-amyloid(25-35)-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate.
    Wang C; Chen T; Li G; Zhou L; Sha S; Chen L
    Neuropharmacology; 2015 Oct; 97():122-32. PubMed ID: 26051402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine.
    Marutle A; Ohmitsu M; Nilbratt M; Greig NH; Nordberg A; Sugaya K
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12506-11. PubMed ID: 17640880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
    Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
    Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
    Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
    Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal network dynamics in response to α7 nACh receptors activation in amyloid-β overproducing transgenic mice.
    Stoiljkovic M; Kelley C; Hajós GP; Nagy D; Koenig G; Leventhal L; Hajós M
    Neurobiol Aging; 2016 Sep; 45():161-168. PubMed ID: 27459936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
    Feuerbach D; Nozulak J; Lingenhoehl K; McAllister K; Hoyer D
    Neurosci Lett; 2007 Apr; 416(1):61-5. PubMed ID: 17314009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
    Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
    Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.
    Lilja AM; Luo Y; Yu QS; Röjdner J; Li Y; Marini AM; Marutle A; Nordberg A; Greig NH
    PLoS One; 2013; 8(1):e54887. PubMed ID: 23382994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents.
    Pieschl RL; Miller R; Jones KM; Post-Munson DJ; Chen P; Newberry K; Benitex Y; Molski T; Morgan D; McDonald IM; Macor JE; Olson RE; Asaka Y; Digavalli S; Easton A; Herrington J; Westphal RS; Lodge NJ; Zaczek R; Bristow LJ; Li YW
    Eur J Pharmacol; 2017 Jul; 807():1-11. PubMed ID: 28438647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neural stem cells alleviate Alzheimer-like pathology in a mouse model.
    Lee IS; Jung K; Kim IS; Lee H; Kim M; Yun S; Hwang K; Shin JE; Park KI
    Mol Neurodegener; 2015 Aug; 10():38. PubMed ID: 26293123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
    Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
    J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway.
    Wang XL; Deng YX; Gao YM; Dong YT; Wang F; Guan ZZ; Hong W; Qi XL
    Aging (Albany NY); 2020 Jan; 12(1):543-570. PubMed ID: 31905173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer's disease mouse model.
    Kim JA; Ha S; Shin KY; Kim S; Lee KJ; Chong YH; Chang KA; Suh YH
    Cell Death Dis; 2015 Jun; 6(6):e1789. PubMed ID: 26086962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.